Christopher B. Prentiss, Chief Financial Officer at Adamas Pharmaceuticals Inc (ADMS), sold 2,422 shares at $5.48 ($13K) on 2021-03-22, disclosed to the SEC on 2021-03-23.
Seasonal sale ($13k) by Chief Financial Officer — this insider has traded ADMS in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ADMS | SELL | 2020-11-02 | $7K | — | Filing → |
| ADMS | SELL | 2020-01-23 | $8K | — | Filing → |
| ADMS | SELL | 2019-07-23 | $6K | — | Filing → |